Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Gout epidemiology: results from the UK General Practice Research Database, 1990-1999.

Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG.

Ann Rheum Dis. 2005 Feb;64(2):267-72.

2.

Contemporary epidemiology of gout in the UK general population.

Cea Soriano L, Rothenbacher D, Choi HK, García Rodríguez LA.

Arthritis Res Ther. 2011 Mar 3;13(2):R39. doi: 10.1186/ar3272.

3.

Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study.

Lu N, Dubreuil M, Zhang Y, Neogi T, Rai SK, Ascherio A, Hernán MA, Choi HK.

Ann Rheum Dis. 2016 Mar;75(3):547-51. doi: 10.1136/annrheumdis-2014-206917. Epub 2015 Mar 4.

4.

Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study.

Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M.

Ann Rheum Dis. 2015 Apr;74(4):661-7. doi: 10.1136/annrheumdis-2013-204463. Epub 2014 Jan 15.

5.

Epidemiology and management of gout in Taiwan: a nationwide population study.

Kuo CF, Grainge MJ, See LC, Yu KH, Luo SF, Zhang W, Doherty M.

Arthritis Res Ther. 2015 Jan 23;17:13. doi: 10.1186/s13075-015-0522-8.

6.

Frequency and risk factors of gout flares in a large population-based cohort of incident gout.

Rothenbacher D, Primatesta P, Ferreira A, Cea-Soriano L, Rodríguez LA.

Rheumatology (Oxford). 2011 May;50(5):973-81. doi: 10.1093/rheumatology/keq363. Epub 2011 Jan 12.

PMID:
21228059
7.

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005.

Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G.

Ann Rheum Dis. 2008 Jul;67(7):960-6. Epub 2007 Nov 2.

8.

Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).

Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG.

Rheumatology (Oxford). 2005 Aug;44(8):1038-42. Epub 2005 May 3.

PMID:
15870145
9.

Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study.

Rho YH, Lu N, Peloquin CE, Man A, Zhu Y, Zhang Y, Choi HK.

Ann Rheum Dis. 2016 Jan;75(1):91-5. doi: 10.1136/annrheumdis-2014-205827. Epub 2014 Oct 2.

10.

Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study.

Trifirò G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, Bianchini E, Medea G, Cricelli C, Caputi AP, Mazzaglia G.

Ann Rheum Dis. 2013 May;72(5):694-700. doi: 10.1136/annrheumdis-2011-201254. Epub 2012 Jun 26.

PMID:
22736095
11.

Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007.

Elliot AJ, Cross KW, Fleming DM.

Ann Rheum Dis. 2009 Nov;68(11):1728-33. doi: 10.1136/ard.2008.096693. Epub 2008 Nov 24.

PMID:
19029167
12.

Use of diuretics and risk of incident gout: a population-based case-control study.

Bruderer S, Bodmer M, Jick SS, Meier CR.

Arthritis Rheumatol. 2014 Jan;66(1):185-96. doi: 10.1002/art.38203. Erratum in: Arthritis Rheumatol. 2014 Feb;66(2):427.

13.

Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population.

Primatesta P, Plana E, Rothenbacher D.

BMC Musculoskelet Disord. 2011 May 20;12:103. doi: 10.1186/1471-2474-12-103.

14.

Demographic and clinical profile of nursing facility residents with gout.

Zarowitz BJ, O'Shea TE.

Consult Pharm. 2013 Jun;28(6):370-82. doi: 10.4140/TCP.n.2013.370.

PMID:
23748125
15.

Individuals With Type 2 Diabetes Mellitus Are at an Increased Risk of Gout But This Is Not Due to Diabetes: A Population-Based Cohort Study.

Wijnands JM, van Durme CM, Driessen JH, Boonen A, Klop C, Leufkens B, Cooper C, Stehouwer CD, de Vries F.

Medicine (Baltimore). 2015 Aug;94(32):e1358. doi: 10.1097/MD.0000000000001358.

16.

Prevalence of contraindications and prescription of pharmacologic therapies for gout.

Keenan RT, O'Brien WR, Lee KH, Crittenden DB, Fisher MC, Goldfarb DS, Krasnokutsky S, Oh C, Pillinger MH.

Am J Med. 2011 Feb;124(2):155-63. doi: 10.1016/j.amjmed.2010.09.012.

PMID:
21295195
17.

Epidemiology of hyperuricemia and gout.

Luk AJ, Simkin PA.

Am J Manag Care. 2005 Nov;11(15 Suppl):S435-42; quiz S465-8. Review.

18.

Sex differences in gout epidemiology: evaluation and treatment.

Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, Chan KA, Roblin D, Raebel MA, Von Worley A, Platt R, Saag KG.

Ann Rheum Dis. 2006 Oct;65(10):1368-72. Epub 2006 Apr 27.

19.

Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study.

Hazra N, Dregan A, Charlton J, Gulliford MC, D'Cruz DP.

Rheumatology (Oxford). 2015 Dec;54(12):2181-7. doi: 10.1093/rheumatology/kev240. Epub 2015 Jul 17.

PMID:
26187053
20.

Prescription and comorbidity screening following consultation for acute gout in primary care.

Roddy E, Mallen CD, Hider SL, Jordan KP.

Rheumatology (Oxford). 2010 Jan;49(1):105-11. doi: 10.1093/rheumatology/kep332. Epub 2009 Nov 17.

PMID:
19920095

Supplemental Content

Support Center